Yin X., Altman T., Rutherford E., West K.A., Wu Y., Choi J., Beck P.L., Kaplan G.G., Dabbagh K., DeSantis T.Z., Iwai, S. A Comparative Evaluation of Tools to Predict Metabolite Profiles From Microbiome Sequencing Data. Front. Microbiol. (2020).
December 4, 2020
Baeza-Raja B., Goodyear A., Liu X., Lam K., Yamamoto L., Li Y., Dodson S. G., McCLure M., Takeuchi T., Kisseleva T., Brenner D.A., Dabbagh K. Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis. Plos one. (2020).
June 3, 2020
Sekido, Y. et al. Some Gammaproteobacteria are enriched within CD14+ macrophages from intestinal lamina propria of Crohn’s disease patients versus mucus. Sci. Rep. 10, 2988 (2020).
February 19, 2020
Ryan, F. et al. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nat Commun. (in press)
January 30, 2020
Narayan, N. R. et al. Piphillin predicts metagenomic composition and dynamics from DADA2-corrected 16S rDNA sequences. BMC Genomics. 21, 56 (2020).
January 17, 2020
Ravilla, R. et al. Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion. Integr. Cancer Ther. 18, (2019).
December 13, 2019
Hagan, T. et al. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell 178, 1313-1328.e13 (2019).
September 5, 2019
Martoni, C. J., Evans, M., Chow, C. T., Chan, L. S. & Leyer, G. Impact of a probiotic product on bowel habits and microbial profile in participants with functional constipation: A randomized controlled trial. J. Dig. Dis. 20, 435–446 (2019).
July 4, 2019
Wollam, J. et al. Microbiota-Produced N -Formyl Peptide fMLF Promotes Obesity-Induced Glucose Intolerance. Diabetes 68, 1415–1426 (2019).
April 22, 2019
Reveles, K. R., Patel, S., Forney, L. & Ross, C. N. Age-related changes in the marmoset gut microbiome. Am. J. Primatol. 81, e22960 (2019).
February 25, 2019